Pharmacy and Pharmaceutical Technology Department 10th-12th March 2003 Parametric and nonparametric population PK and PD modelling. Aplications in Therapeutic Drug Monitoring
12:00 Continous response modelling. Dra. A. Aldaz.
Faculty
12:30 The behaviour of Efavirenz. Dr. NV Jimenez Torres.
Azucena Aldaz Pastor, Facultad de Farmacia, Universidad
10 de Marzo de 2003
13:00 The behaviour of Cyclosporine. Dra. B. Porta.
9:30 Welcome. Dr. R. Jelliffe and Dr. NV Jiménez Torres
Aida Bustad, B.A. Lab of Applied Pharmacokinetics, USC
9:45 Introduction to basic concepts in population pharmacokinetics.
15:00 Computer clusters and Web access for making
Gustavo Camps. Facultad de Físicas, Universidad de
11:00 Nonparametric population models, NPML, NPEM. Dr. R.
15:30 Making large and nonlinear population models. Dr.
Vicente G. Casabó,. Facultad de Farmacia, Universidad de
16:00 Using BOXES making a Michaelis-Menten model of
Nils Hoem. School of Pharmacy, University of Oslo, Norway.
11:45 Nonparametric Adaptive Grid, NPAG, modelling. Dr. R.
Roger W. Jelliffe, Lab of Applied Pharmacokinetics, USC
16:30 Demo setting up Big IT2B and NPEM modelling
Víctor Jiménez Torres, Facultad de Farmacia, Universidad
Iterative 2 stage Bayesian. Dr. R. Jelliffe.
17:30 Hands-on session – Managing a patient on Digoxin.
José David Martín Facultad de Físicas, Universidad de
Matilde Merino Sanjuán, Facultad de Farmacia, Universidad
13:30 Neural Network modelling: A New paradigm?. Dr. E. Soria.
12 de Marzo de 2003
9:30 Pharmacokinetic and pharmacodynamic (PK/PD)
Juan José Pérez Ruixó. Johnson & Johnson Pharmaceutical
modelling and simulation in oncology. Dr. JJ
Research & Development, a Division of Janssen
15:30 Hand-on session getting the assay error polynomial. Dr. R.
Begoña Porta, Servicio de Farmacia, Hospital Universitario
11:30 The behaviour of Cyclofosfamide. Dr. JJ. Pérez
15:45 Entering and storing past doses and levels, analysing the
Emilio Soria Olivas, Facultad de Físicas, Universidad de
12:00 The behaviour of 5-Fluoracil. Dra. M. Merino
12:30 The behaviour of Paclitaxel. Dr. NV Jiménez Torres
Chairmen
13:00 The behaviour of Gentamicin. Dr. VG Casabó
Coordinators Modelling with neural networks: some pharmaceutical examples
18:00 Demo Vancomycin. Setting the initial goals, planning the
Organized by
18:15 Hands on session. Setting the initial goals, planning the
Pharmacy and Pharmaceutical Technology Department.
University of Valencia. Laboratory of Applied
Pharmacoknetics, University of Southern California.
11 de Marzo de 2003
Pharmacy Department University Hospital of Navarra.
9:30 Comparing parametric and non parametric approaches. IT2B,
More information:
Pharmacy and Pharmaceutical Thecnology Department.
10:00 Multiple model (MM) dosage design for maximum precision
10:30 Getting MM Bayesian posterior individual parameter
11:30 Dicotomous and ordinal response modelling. Dr. VG Casabó
ACKNOWLEDGMENT OF ORDER AND TERMS AND CONDITIONS OF SALE This is to acknowledge receipt of your ("Buyer") purchase order for the specified products (the "Products") of ELANTAS PDG,INC. ("Seller") and to set forth the terms and conditions ("Terms and Conditions")of sale for this order. If the Terms and Conditions of this acknowledgment differ in any way from the t
F, NUTR_DEF 2011.08.29 2011.07.25 FNUTRDEF.PRG #146 NUTR_NO,UNITS,TAGNAME, NUTRDESC, .num_dec , SR_ORDER You may select any of these nutrients for research purposes The values will be as per the USAD REL 24 TABLES 203 , g PROCNT PROTEIN .2 ,600 204 , g FAT TOTAL LIPID (FAT) .2 ,800 205 , g CHOCDF CARBOHYDRATE, BY DIFFERENCE .2 ,1100 207 , g ASH ASH .2 ,1000 208 , kcal ENERC_KCAL ENERGY .0 ,300 20